Author
@himshouse himshouse
grade Cx.com/himshouse ↗
Obsessive single-name HIMS tracker riding the GLP-1/peptide obesity-drug wave.
Aggregates and synthesizes news, analyst actions, channel/ap
trader score
+2.90
hit rate
65%
mean α
+2.89%
signals 14d
78
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Across their last 20 scored bets: 65% hit rate, +2.89% mean alpha, trader score +2.90. Their last-14d mentions, direction-adjusted, have moved +4.8% since posting (mean over 73 mentions with price data).
Recent signals15receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-07-02 | HIMS | @himshouse | +0.35 | Highlights large obesity market alongside HIMS ticker. | — | tweet ↗ |
| 2026-07-02 | LLY | @himshouse | -0.25 | Reports unregulated GLP-1-like sales, implying competitive or safety overhang for named obesity-drug tickers. | — | tweet ↗ |
| 2026-07-02 | HIMS | @himshouse | -0.20 | Reports unregulated GLP-1-like sales, implying competitive or safety overhang for named obesity-drug tickers. | — | tweet ↗ |
| 2026-07-02 | NVO | @himshouse | -0.25 | Reports unregulated GLP-1-like sales, implying competitive or safety overhang for named obesity-drug tickers. | — | tweet ↗ |
| 2026-07-01 | HIMS | @himshouse | +0.25 | Reports HIMS set up a $400M receivables deal with J.P. Morgan as cash-flow tool. | -2.0% | tweet ↗ |
| 2026-07-01 | HIMS | @himshouse | +0.05 | Summarizes analyst PT distribution and rating counts for HIMS. | -2.0% | tweet ↗ |
| 2026-07-01 | NFLX | @himshouse | +0.00 | Quotes former NFLX CFO praising HIMS CEO Andrew Dudum as a listener. | +4.7% | tweet ↗ |
| 2026-07-01 | HIMS | @himshouse | +0.25 | Quotes former NFLX CFO praising HIMS CEO Andrew Dudum as a listener. | -2.0% | tweet ↗ |
| 2026-07-01 | HIMS | @himshouse | +0.30 | Board member explains why he joined HIMS board and praises innovation/disruption. | -2.0% | tweet ↗ |
| 2026-07-01 | HIMS | @himshouse | +0.45 | Cites Needham base case still assumes peptide approval. | -2.0% | tweet ↗ |
| 2026-07-01 | HIMS | @himshouse | +0.35 | Mocks prior consensus that HIMS was going to zero. | -2.0% | tweet ↗ |
| 2026-07-01 | HIMS | @himshouse | +0.45 | Reports David Wells bought 48,000 HIMS shares at $24.24, about $1.2M. | -2.0% | tweet ↗ |
| 2026-07-01 | HIMS | @himshouse | +0.25 | Bank of America raises HIMS PT to $36 from $25 with Hold rating. | -2.0% | tweet ↗ |
| 2026-07-01 | HIMS | @himshouse | +0.35 | Promotes interview explaining board member David Wells' $1.2M HIMS share purchase. | -2.0% | tweet ↗ |
| 2026-07-01 | LLY | @himshouse | +0.30 | Wegovy available to eligible Medicare patients via bridge program with $50 monthly copay. | +1.9% | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.